IDEAYA Biosciences, Inc. (IDYA)
NASDAQ: IDYA · Real-Time Price · USD
26.79
+0.19 (0.71%)
Nov 22, 2024, 4:00 PM EST - Market closed
IDEAYA Biosciences Employees
IDEAYA Biosciences had 124 employees as of December 31, 2023. The number of employees increased by 21 or 20.39% compared to the previous year.
Employees
124
Change (1Y)
21
Growth (1Y)
20.39%
Revenue / Employee
$31,629
Profits / Employee
-$1,436,452
Market Cap
2.32B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| CONMED | 4,000 |
| UFP Technologies | 3,093 |
| iRhythm Technologies | 2,000 |
| Alignment Healthcare | 1,536 |
| LeMaitre Vascular | 630 |
| Arrowhead Pharmaceuticals | 525 |
| Geron | 141 |
| Keros Therapeutics | 136 |
IDYA News
- 5 days ago - IDEAYA Biosciences Appoints Stu Dorman as Chief Commercial Officer - PRNewsWire
- 11 days ago - IDEAYA Biosciences Announces Participation in Jefferies London Healthcare Conference and Plans for Investor R&D Day - PRNewsWire
- 12 days ago - IDEAYA Announces Development Candidate Nomination of IDE034, a Potential First-in-Class B7H3/PTK7 Topo-I-Payload Bispecific ADC and Option Exercise with Biocytogen - PRNewsWire
- 12 days ago - Biocytogen Announces IDEAYA's Nomination of Development Candidate IDE034, a Potential First-in-Class B7H3/PTK7 Topo-I-Payload Bispecific ADC and Option Exercise - Business Wire
- 19 days ago - IDEAYA Biosciences, Inc. Reports Third Quarter 2024 Financial Results and Provides Business Update - PRNewsWire
- 22 days ago - IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - PRNewsWire
- 26 days ago - IDEAYA Biosciences Announces IND-Clearance for Werner Helicase Development Candidate IDE275 (GSK959) for a Phase 1 Study in MSI-High Solid Tumors - PRNewsWire
- 4 weeks ago - IDEAYA Announces Positive Interim Phase 1 Expansion Data of IDE397 in MTAP-Deletion Urothelial and Lung Cancer as Late-Breaker Oral Presentation at EORTC-NCI-AACR 2024 - PRNewsWire